CDKN2A and esophageal small cell neuroendocrine carcinoma: Fujimasa et al. reported that p16 overexpression and Rb1 protein loss were highly specific findings in esophageal small-cell carcinomas and their immunoreactivity could serve as a potentially useful diagnostic marker [12].